Tantum Verde 3mg Eucalyptus-flavoured oral lozenges, 40pcs

Composition

Per tablet for resorption: Active ingredient-benzydamine hydrochloride-3 mg. Auxiliary ingredients: isomaltose 3183 mg, ramenta 4 mg, aspartame 3.5 mg, citric acid monohydrate 2 mg, mint flavor 5 mg, lemon flavor,1.5 mg, dye quinoline yellow (E 104) 0,035 mg, dye Indigo Carmine (E 132) 0,015 mg.

Pharmacological action

of nonsteroidal anti-inflammatory preparado ATKH: 01AD02 AND Pharmacological properties. Pharmacodynamics Benzydamine is a nonsteroidal anti-inflammatory drug belongs to the group of indazoles. It has an anti-inflammatory and local analgesic effect, has an antiseptic effect against a wide range of microorganisms. The mechanism of action of the drug is associated with the stabilization of cell membranes and inhibition of prostaglandin synthesis. Benzydamine has an antibacterial and specific antimicrobial effect due to the rapid penetration of microorganisms through the membranes, followed by damage to cellular structures, disruption of metabolic processes and cell lysosomes. It has an antifungal effect against Candida albicans. It causes structural modifications of the cell wall of fungi and their metabolic chains, thus preventing their reproduction, which was the basis for the use of benzydamine in inflammatory processes in the oral cavity, including infectious etiology. Pharmacokinetics When applied topically, the drug is well absorbed through the mucous membranes and penetrates into inflamed tissues, it is found in blood plasma in an amount insufficient to produce systemic effects. Excretion of the drug occurs mainly by the kidneys, in the form of inactive metabolites or conjugation products.

Indications

Symptomatic therapy of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies): – gingivitis, glossitis, stomatitis (including after radiation and chemotherapy);-pharyngitis, laryngitis, tonsillitis; – candidiasis of the oral mucosa (as part of combination therapy);- calculous inflammation of the salivary glands; – after surgical interventions and injuries (tonsillectomy, jaw fractures)-after treatment and tooth extraction;- periodontal disease;For infectious and inflammatory diseases requiring systemic treatment, the use of Tantum®is necessary Verde in combination therapy.

Use during pregnancy and lactation

Tantum®preparation Verde should not be used during pregnancy and lactation.

Contraindications

• Hypersensitivity to benzydamine or other components of the drug;
• fructose intolerance;
• children under 6 years of age;
• phenylketonuria

With caution: hypersensitivity to acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs, bronchial asthma (including in the anamnesis).

Side effects

World Health Organization (WHO)classification of the incidence of side effects: very common – ≥1/10; common – ≥ 1/100 to <1/10; uncommon – ≥1/1000 to <1/100; rare – ≥1/10000 to <1/1000;very rare — In each group, undesirable effects are presented in decreasing order of severity. Local reactions: rarely-dry mouth, burning sensation in the oral cavity; frequency unknown-feeling of numbness in the oral cavity. Allergic reactions: infrequently-photosensitization; rarely-hypersensitivity reactions. skin rash, pruritus; very rare – angioedema, laryngospasm; frequency unknown – anaphylactic reactions. If any of the side effects listed in the instructions get worse, or any other side effects that are not listed in the instructions are noted, you should immediately inform your doctor.

Interaction

Interaction studies with other drugs have not been conducted.

How to take, course of use and dosage

Locally, after a meal. Adults (including elderly patients) and children over 6 years of age: 1 tablet for resorption 3 times a day. Tablets should be kept in the mouth until completely dissolved. Do not swallow. Don’t chew it. Do not exceed the recommended dose. For children from 6 to 12 years of age, the use of the drug is carried out under the supervision of an adult. The duration of treatment should not exceed 7 days. If there is no improvement after treatment within 7 days or new symptoms appear, you should consult your doctor. Use the drug only according to the method of use and in the doses indicated in the instructions. If necessary, please consult your doctor before using the medicine.

Overdose

Currently, cases of overdose of Tantum®have been reported Verde was not informed. Symptoms: if the drug is used in accordance with the instructions for use, overdose is unlikely. If the drug is accidentally swallowed, the following symptoms may occur: vomiting, abdominal cramps, anxiety, fear, hallucinations, convulsions, ataxia, fever, tachycardia, respiratory depression. Treatment: symptomatic; clear the stomach by inducing vomiting or flush the stomach using a gastric tube (under the supervision of a doctor); provide medical supervision, supportive therapy and necessary hydration. The antidote is not known.

Special instructions

When using the drug Tantum® Verde may develop hypersensitivity reactions. In this case, it is recommended to stop treatment and consult a doctor to prescribe appropriate therapy. In a limited number of patients, the presence of ulcers in the throat and oral cavity may indicate the presence of a more serious pathology. If symptoms persist for more than 3 days, you should consult your doctor. Application of the drug Tantum® Verde is not recommended in patients with hypersensitivity to acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs. Tantum®preparation Verde should be used with caution in patients with a history of bronchial asthma due to the possibility of developing bronchospasm while taking the drug. The drug contains isomaltose and, therefore, is not recommended in patients with hereditary fructose intolerance. The use of the drug in children is possible only under the supervision of adults in order to avoid swallowing the tablet. Influence on the ability to drive vehicles, mechanismm does not affect the ability to drive vehicles and work with mechanisms.

Storage conditions

At a temperature not exceeding 25° C, in a place protected from light. Keep out of reach of children.

Shelf

life is 4 years.

Active ingredient

Benzydamine

Dosage form

tablets for resorption

Description

For adults and Children over 6 years of age

Indications

Tonsillitis, Oral Inflammation, Pharyngitis, Gum Inflammation, Stomatitis, Sore Throat, Laryngitis